Owens & Minor, Inc. (NYSE:OMI) Position Lessened by Phocas Financial Corp.

Phocas Financial Corp. trimmed its position in shares of Owens & Minor, Inc. (NYSE:OMI) by 85.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,601 shares of the company’s stock after selling 184,363 shares during the period. Phocas Financial Corp.’s holdings in Owens & Minor were worth $426,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Royce & Associates LP raised its holdings in shares of Owens & Minor by 179.4% during the third quarter. Royce & Associates LP now owns 80,914 shares of the company’s stock worth $1,270,000 after acquiring an additional 51,955 shares in the last quarter. FMR LLC raised its holdings in shares of Owens & Minor by 0.8% during the third quarter. FMR LLC now owns 11,564,624 shares of the company’s stock worth $181,449,000 after acquiring an additional 90,862 shares in the last quarter. Waldron Private Wealth LLC purchased a new stake in shares of Owens & Minor during the fourth quarter worth $406,000. JPMorgan Chase & Co. raised its holdings in shares of Owens & Minor by 68.4% during the third quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock worth $5,912,000 after acquiring an additional 152,999 shares in the last quarter. Finally, Foundry Partners LLC purchased a new stake in shares of Owens & Minor during the third quarter worth $5,238,000. 98.04% of the stock is currently owned by hedge funds and other institutional investors.

Owens & Minor Price Performance

NYSE OMI opened at $6.84 on Thursday. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The stock’s 50-day moving average is $11.68 and its two-hundred day moving average is $13.35. The firm has a market cap of $527.04 million, a P/E ratio of -10.52, a price-to-earnings-growth ratio of 0.20 and a beta of 0.48. Owens & Minor, Inc. has a fifty-two week low of $6.07 and a fifty-two week high of $28.35.

Wall Street Analyst Weigh In

Several analysts recently issued reports on OMI shares. Citigroup cut their price objective on Owens & Minor from $21.00 to $18.50 and set a “buy” rating for the company in a report on Tuesday, November 5th. Barclays cut their target price on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 5th. UBS Group cut their target price on Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Finally, Robert W. Baird cut their target price on Owens & Minor from $14.00 to $10.00 and set a “neutral” rating on the stock in a report on Tuesday. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $14.92.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.